Medical Cannabis for Intractable Epilepsy in Childhood: A Review
- PMID: 32017679
- PMCID: PMC7000162
- DOI: 10.5041/RMMJ.10387
Medical Cannabis for Intractable Epilepsy in Childhood: A Review
Abstract
In recent years, cannabis has been gaining increasing interest in both the medical research and clinical fields, with regard to its therapeutic effects in various disorders. One of the major fields of interest is its role as an anticonvulsant for refractory epilepsy, especially in the pediatric population. This paper presents and discusses the current accumulated knowledge regarding artisanal cannabis and Epidiolex®, a United States Food and Drug Administration (FDA)-approved pure cannabidiol (CBD), in epilepsy management in pediatrics, by reviewing the literature and raising debate regarding further research directions.
Conflict of interest statement
Similar articles
-
Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.Epilepsy Behav. 2018 Mar;80:240-246. doi: 10.1016/j.yebeh.2018.01.026. Epub 2018 Feb 9. Epilepsy Behav. 2018. PMID: 29429908
-
Medical Marijuana in the Pediatric Population With Epilepsy-What You Should Know.J Pediatr Health Care. 2019 Nov-Dec;33(6):626-632. doi: 10.1016/j.pedhc.2019.03.002. Epub 2019 Jun 1. J Pediatr Health Care. 2019. PMID: 31160106 Review.
-
Cannabis for the Treatment of Epilepsy: an Update.Curr Neurol Neurosci Rep. 2018 Sep 8;18(11):73. doi: 10.1007/s11910-018-0882-y. Curr Neurol Neurosci Rep. 2018. PMID: 30194563 Review.
-
Epidiolex as adjunct therapy for treatment of refractory epilepsy: a comprehensive review with a focus on adverse effects.F1000Res. 2019 Feb 28;8:F1000 Faculty Rev-234. doi: 10.12688/f1000research.16515.1. eCollection 2019. F1000Res. 2019. PMID: 30854190 Free PMC article. Review.
-
The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.Epilepsy Behav. 2017 May;70(Pt B):288-291. doi: 10.1016/j.yebeh.2016.11.021. Epub 2017 Feb 4. Epilepsy Behav. 2017. PMID: 28169144 Review.
Cited by
-
New Pharmacological Therapies in the Treatment of Epilepsy in the Pediatric Population.J Clin Med. 2024 Jun 18;13(12):3567. doi: 10.3390/jcm13123567. J Clin Med. 2024. PMID: 38930098 Free PMC article. Review.
-
Use of Cannabis-Based Medical Products for Pediatric Health Conditions: A Systematic Review of the Recent Literature.Med Cannabis Cannabinoids. 2024 Dec 10;7(1):257-267. doi: 10.1159/000542550. eCollection 2024 Jan-Dec. Med Cannabis Cannabinoids. 2024. PMID: 39659365 Free PMC article. Review.
-
Clinical Outcome Data of Children Treated with Cannabis-Based Medicinal Products for Treatment Resistant Epilepsy-Analysis from the UK Medical Cannabis Registry.Neuropediatrics. 2023 Jun;54(3):174-181. doi: 10.1055/a-2002-2119. Epub 2022 Dec 20. Neuropediatrics. 2023. PMID: 36539215 Free PMC article.
-
Cardiac Transplantation and the Use of Cannabis.Life (Basel). 2021 Oct 9;11(10):1063. doi: 10.3390/life11101063. Life (Basel). 2021. PMID: 34685434 Free PMC article. Review.
-
Real-World Evidence of Factors Affecting Cannabidiol Exposure in Children with Drug-Resistant Developmental and Epileptic Encephalopathies.Pharmaceutics. 2023 Aug 10;15(8):2120. doi: 10.3390/pharmaceutics15082120. Pharmaceutics. 2023. PMID: 37631333 Free PMC article.
References
-
- Gowers W. Epilepsy and Other Chronic Convulsive Disorders. London: Churchill; 1881.
-
- Consroe P, Wolkin A. Cannabidiol–antiepileptic drug comparisons and interactions in experimentally induced seizures in rats. J Pharmacol Exp Ther. 1977;201:26–32. - PubMed
Publication types
LinkOut - more resources
Full Text Sources